SNPS icon

Synopsys

529.75 USD
+3.05
0.58%
At close Jan 21, 4:00 PM EST
After hours
530.14
+0.39
0.07%
1 day
0.58%
5 days
7.53%
1 month
7.55%
3 months
4.78%
6 months
-9.86%
Year to date
9.74%
1 year
-2.21%
5 years
244.93%
10 years
1,148.53%
 

About: Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Employees: 20,300

0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 9 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

14% more repeat investments, than reductions

Existing positions increased: 493 | Existing positions reduced: 433

1% more first-time investments, than exits

New positions opened: 128 | Existing positions closed: 127

1% less funds holding

Funds holding: 1,231 [Q2] → 1,217 (-14) [Q3]

4.73% less ownership

Funds ownership: 92.21% [Q2] → 87.48% (-4.73%) [Q3]

19% less capital invested

Capital invested by funds: $83.9B [Q2] → $68.1B (-$15.9B) [Q3]

31% less call options, than puts

Call options by funds: $712M | Put options by funds: $1.04B

34% less funds holding in top 10

Funds holding in top 10: 32 [Q2] → 21 (-11) [Q3]

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$540
2%
upside
Avg. target
$624
18%
upside
High target
$675
27%
upside

9 analyst ratings

positive
78%
neutral
22%
negative
0%
Redburn Atlantic
Lachlan Brown
80% 1-year accuracy
4 / 5 met price target
13%upside
$600
Buy
Initiated
13 Jan 2025
Wells Fargo
Joe Quatrochi
29% 1-year accuracy
2 / 7 met price target
2%upside
$540
Equal-Weight
Maintained
13 Jan 2025
Piper Sandler
Clarke Jeffries
58% 1-year accuracy
30 / 52 met price target
24%upside
$655
Overweight
Maintained
6 Dec 2024
Baird
Joe Vruwink
38% 1-year accuracy
16 / 42 met price target
19%upside
$630
Outperform
Maintained
5 Dec 2024
Rosenblatt
Blair Abernethy
49% 1-year accuracy
26 / 53 met price target
25%upside
$660
Buy
Maintained
5 Dec 2024

Financial journalist opinion

Based on 21 articles about SNPS published over the past 30 days

Neutral
Zacks Investment Research
5 days ago
Synopsys (SNPS) Advances While Market Declines: Some Information for Investors
Synopsys (SNPS) reachead $515.81 at the closing of the latest trading day, reflecting a +1.7% change compared to its last close.
Synopsys (SNPS) Advances While Market Declines: Some Information for Investors
Neutral
Seeking Alpha
5 days ago
Synopsys, Inc. (SNPS) 27th Annual Needham Growth Conference (Transcript)
Synopsys, Inc. (NASDAQ:SNPS ) 27th Annual Needham Growth Conference January 16, 2025 11:00 AM ET Company Participants Shelagh Glaser - CFO Conference Call Participants Charles Shi - Needham & Company Charles Shi Good morning. Welcome to the 27th Annual Needham Growth Conference.
Synopsys, Inc. (SNPS) 27th Annual Needham Growth Conference (Transcript)
Positive
Zacks Investment Research
5 days ago
Here is What to Know Beyond Why Synopsys, Inc. (SNPS) is a Trending Stock
Zacks.com users have recently been watching Synopsys (SNPS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Here is What to Know Beyond Why Synopsys, Inc. (SNPS) is a Trending Stock
Neutral
Zacks Investment Research
1 week ago
Synopsys Plunges 20% in 6 Months: Should You Buy the Dip?
SNPS is affected by the U.S.-China trade war and slow recovery across key business segments. Yet, its strategic collaborations and AI investments are upsides.
Synopsys Plunges 20% in 6 Months: Should You Buy the Dip?
Positive
Benzinga
1 week ago
Nvidia, Marvell, Synopsys Demonstrate AI Leadership And Strong Chip Design Momentum: Analyst
Companies exposed to artificial intelligence and accelerated computing have continued to see their end demand and visibility strengthen.
Nvidia, Marvell, Synopsys Demonstrate AI Leadership And Strong Chip Design Momentum: Analyst
Neutral
PRNewsWire
1 week ago
Synopsys Responds to the European Commission Approving its Proposed Acquisition of Ansys in Phase 1
SUNNYVALE, Calif. , Jan. 10, 2025 /PRNewswire/ -- Today, Synopsys issued the following statement in response to the European Commission (EC) approving its proposed acquisition of Ansys in Phase 1: "We are very pleased that the EC has approved our pro-competitive transaction in Phase 1.
Synopsys Responds to the European Commission Approving its Proposed Acquisition of Ansys in Phase 1
Positive
TechCrunch
1 week ago
EU approves $35B Synopsys and Ansys merger, subject to divestment conditions
The European Commission (EC) has given the greenlight for Synopsys to acquire Ansys, though the companies must divest some half-a-dozen products as part of the proposed remedies.
EU approves $35B Synopsys and Ansys merger, subject to divestment conditions
Positive
WSJ
1 week ago
EU Competition Regulator Conditionally Clears Synopsys' $35 Billion Ansys Deal
The commission said that the companies' offer to sell two business units to a rival fully addresses its concerns.
EU Competition Regulator Conditionally Clears Synopsys' $35 Billion Ansys Deal
Positive
Reuters
1 week ago
EU approves Synopsys' $35 billion Ansys deal under conditions
The European Commission on Friday said it had approved under conditions the takeover by chip design software maker Synopsys of software company Ansys , a $35 billion cash-and-stock deal announced in January last year.
EU approves Synopsys' $35 billion Ansys deal under conditions
Neutral
PRNewsWire
1 week ago
Synopsys Responds to the UK Competition and Markets Authority Provisionally Accepting its Proposed Remedies in Phase 1 Regarding its Proposed Acquisition of Ansys
SUNNYVALE, Calif. , Jan. 8, 2025 /PRNewswire/ -- Today, Synopsys issued the following statement in response to the UK Competition and Markets Authority (CMA) provisionally accepting its proposed remedies in Phase 1 regarding its proposed acquisition of Ansys: "We are very pleased that today the CMA has taken the important step of provisionally accepting our proposed remedies in Phase 1 rather than referring the transaction to Phase 2.
Synopsys Responds to the UK Competition and Markets Authority Provisionally Accepting its Proposed Remedies in Phase 1 Regarding its Proposed Acquisition of Ansys
Charts implemented using Lightweight Charts™